Literature DB >> 7284846

Catecholamine levels and turnover during aging in brain regions of male C57BL/6J mice.

H H Osterburg, H G Donahue, J A Severson, C E Finch.   

Abstract

A radioenzymatic assay is described for measuring brain catecholamines (CA) and 3,4-dihydroxyphenylacetic acid (DOPAC) in the same tissue extract. The [3H]-methylated products are differentially extracted and then acetylated by acetic anhydride, followed by thin layer chromatography in non-basic solvents. Routine sensitivity is 3-5 pg per sample. This assay gave CA levels in brain regions which generally agreed with previous reports. CA levels/mg protein and turnover (after injection of a-methyl-p-tyrosine) were measured in male C57BL/6J mice at various ages between 4 and 30 months, the average lifespan of male C57BL/6J mice. No region showed progressive age changes in levels or turnover, or changes before midlife, 8-12 months. Brain regions with no evidence of age changes include globus pallidus, zona incerta, substantia nigra, cerebellum, and olfactory bulbs. Small changes (10-25%) were detected in only some regions of mice aged greater than or equal to 24 months; few changes were statistically significant. CA levels and turnover decreased in some samplings of striatum and median eminence-arcuate nucleus. In contrast, DA levels increased in anterior pituitary and possibly in medial preoptic region. DOPAC levels (measured only in rostral striatum) decreased by 20% at 28 months. These results diverge from the larger, progressive decreases of DA reported in human striatum during aging.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7284846     DOI: 10.1016/0006-8993(81)90864-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  Dopamine agonist-induced stereotypic grooming and self-mutilation following striatal dopamine depletion.

Authors:  S L Hartgraves; P K Randall
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Effect of aging on monoamines and their metabolites in the rat brain.

Authors:  A Moretti; N Carfagna; F Trunzo
Journal:  Neurochem Res       Date:  1987-11       Impact factor: 3.996

3.  Decreased vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) function in knockout mice affects aging of dopaminergic systems.

Authors:  F S Hall; K Itokawa; A Schmitt; R Moessner; I Sora; K P Lesch; G R Uhl
Journal:  Neuropharmacology       Date:  2013-08-24       Impact factor: 5.250

4.  Inhibition of Nigral Microglial Activation Reduces Age-Related Loss of Dopaminergic Neurons and Motor Deficits.

Authors:  Tzu-Feng Wang; Shih-Ying Wu; Bo-Syong Pan; Sheng-Feng Tsai; Yu-Min Kuo
Journal:  Cells       Date:  2022-01-30       Impact factor: 6.600

5.  Aging-related motor function and dopaminergic neuronal loss in C57BL/6 mice.

Authors:  Sachiko Noda; Shigeto Sato; Takahiro Fukuda; Norihiro Tada; Nobutaka Hattori
Journal:  Mol Brain       Date:  2020-03-23       Impact factor: 4.041

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.